Palvella Therapeutics (PVLA) Research & Development (2016 - 2024)
Historic Research & Development for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2024 value amounting to $2.5 million.
- Palvella Therapeutics' Research & Development rose 10890.59% to $2.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $8.2 million, marking a year-over-year decrease of 730.13%. This contributed to the annual value of $8.2 million for FY2024, which is 730.13% down from last year.
- According to the latest figures from Q4 2024, Palvella Therapeutics' Research & Development is $2.5 million, which was up 10890.59% from $3.2 million recorded in Q3 2024.
- In the past 5 years, Palvella Therapeutics' Research & Development ranged from a high of $18.9 million in Q3 2021 and a low of -$28.6 million during Q4 2023
- For the 5-year period, Palvella Therapeutics' Research & Development averaged around $9.2 million, with its median value being $12.4 million (2020).
- Its Research & Development has fluctuated over the past 5 years, first plummeted by 31340.81% in 2023, then soared by 10890.59% in 2024.
- Over the past 5 years, Palvella Therapeutics' Research & Development (Quarter) stood at $10.6 million in 2020, then soared by 44.63% to $15.4 million in 2021, then fell by 12.87% to $13.4 million in 2022, then tumbled by 313.41% to -$28.6 million in 2023, then skyrocketed by 108.91% to $2.5 million in 2024.
- Its last three reported values are $2.5 million in Q4 2024, $3.2 million for Q3 2024, and $1.4 million during Q2 2024.